Unanswered questions, the epidemiology of a community outbreak: meningococcal C disease in Northland, New Zealand, 2011.
نویسندگان
چکیده
AIM We describe the epidemiology of a community outbreak of Meningococcal C disease in Northland in 2011, and national trends in serogroup C disease in New Zealand. METHODS Notification data from EpiSurv for all meningococcal C cases were analysed for 2011 for Northland and for the period 2001-2011 nationally. RESULTS In 2011, the rate of group C meningococcal disease for the population in the Whangarei district aged less than 20 years was 27.6 cases per 100,000 population (6 cases) compared with 17.6 cases per 100,000 population under 20 years (8 cases) in the Northland District Health Board (DHB). All except one case were under 20 years of age. The case fatality rate was 33%. Nationally the rate of meningococcal C disease has fluctuated over the last decade, with an increasing trend apparent since 2007. There has been a noticeable increase over the last 3 years of group C cases infected with the C:P1.5-1,10-8 strain (including all of the Northland cases). This strain has also been associated with a higher case fatality rate (16% in the period 2007-2011). CONCLUSION Meningococcal C disease in New Zealand, although still less common than group B, is poorly understood. The relationships between carriage, invasive disease and community outbreaks deserve greater study. Active monitoring of surveillance data is warranted to ensure timely funded introduction of the highly effective meningococcal C conjugate vaccine on to the national immunisation schedule when appropriate, given increasing disease rates, the high case fatality rate and significant Maori non-Maori inequities in disease incidence.
منابع مشابه
The Northland emergency meningococcal C vaccination programme.
AIM This paper describes an emergency meningococcal C vaccination programme implemented in Northland, New Zealand in 2011. The programme aimed to reduce the impact of a meningococcal group C outbreak on the Northland population, through vaccination of 85% of children and youth 12 months to <20 years with a meningococcal serogroup C conjugate vaccine. METHOD The emergency vaccination programme...
متن کاملThe epidemiology of acute rheumatic fever in Northland, 2002-2011.
AIM An audit of rheumatic fever surveillance in Northland was carried out for the period 2002-2011. The aim of the audit was to establish the accuracy and completeness of surveillance of Acute Rheumatic Fever in Northland, and to provide a robust baseline for future comparison given current rheumatic fever prevention efforts. METHODS Cases of acute rheumatic fever (2002-2011) were identified ...
متن کاملA community outbreak of meningococcal serogroup B disease in western Sydney: the challenges of identification and significance.
The Communicable Diseases Network Australia guidelines provide information for early clinical and public health management of meningococcal disease, including community outbreaks. While community outbreaks of meningococcal serogroup C infections have been reported, community outbreaks of meningococcal serogroup B infections have not been declared in Australia. Three cases of meningococcal serog...
متن کاملVaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
Emergence of serogroup B meningococci of clonal complex sequence type (ST) 41/44 can cause high levels of disease, as exemplified by a recent epidemic in New Zealand. Multiplication of annual incidence rates (3.1 cases/100,000 population) of meningococcal disease in a defined German region, the city of Aachen and 3 neighboring countries (Greater Aachen) prompted us to investigate and determine ...
متن کاملUse of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
BACKGROUND In July 2004 a strain-specific vaccine was introduced to combat an epidemic of group B meningococcal disease in New Zealand. We estimated the effectiveness of this vaccine in pre-school-aged children. METHODS We conducted a cohort analysis of all children in New Zealand who were aged 6 months to <5 years at the time the vaccine became available for that age group in their area. We ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The New Zealand medical journal
دوره 126 1373 شماره
صفحات -
تاریخ انتشار 2013